Note: Ingredients listed on restricted chemical lists
EC/CAS
202-859-9/100-51-6
Name of the chemical
Benzyl Alcohol
Concentration
<2
EC/CAS
215-540-4/1330-43-4
Name of the chemical
Disodium tetraborate
Concentration
<0.9
EC/CAS
233-139-2/10043-35-3
Name of the chemical
Borsäure Borsäure
Concentration
<0.5
EC/CAS
247-852-1/26628-22-8
Name of the chemical
Sodium Azide
Concentration
<0.1
General Information
Version
5.1
Revision date
2021-11-01
Product name
NycoCard CRP
1.2.1 Relevant identified uses
Professional use
supplier name
Abbott Diagnostics Technologies AS
Manufacturer Name
Abbott Diagnostics Technologies AS
Emergency telephone
+1 703-527-3887, +1 800-424-9300, +44 191 2606182, +44 191 2606180
Icons in SDS
Company Information
company name
Abbott Diagnostics Technologies AS
e-mail address of the competent person responsible for the Safety Data Sheet
ATN_customerservice@abbott.com
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
No additional information available
Supplemental label elements
EUH210 - Safety data sheet available on request.
Other hazards which do not result in classification
None under normal conditions. This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Component disodium tetraborate, anhydrous(1330-43-4) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 boric acid(10043-35-3) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605
2.1 Classification of the substance or mixture
Labelling according to Regulation (EC) No. 1272/2008 [CLP] EUH-statements : EUH210 - Safety data sheet available on request.
